- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
UK employees ‘liked’ a US LinkedIn post about a Phase 3 trial for Enhertu. The Panel said the ‘likes’ proactively disseminated the…
Six UK-based Lilly staff ‘liked’ a US corporate LinkedIn post about investigational tirzepatide trial results. PMCPA ruled this proactively disseminated unlicensed promotion…
Anonymous nurse alleged a Sanofi account executive pressured them to sign up to a diabetes therapy review service “as a favour”. Panel…
Complaint alleged off-label promotion linking Pergoveris to IVF and that a study slide lacked key methodological limitations. PMCPA Panel ruled no breach…
Roche UK hosted disease education pages on roche.co.uk that the Panel said were in scope of the ABPI Code and required certification.…
UsForThem complained about a BBC Health article quoting Pfizer’s CEO on vaccinating 5–11s. Appeal Board found breaches for misleading, unsubstantiated, unbalanced public…
Two companies breached Clause 5.1 after advisors signed contracts for a T-DXd 2L mBC advisory board without sufficient detail on the specific…
A complaint alleged promotion of Nucala (mepolizumab) on LinkedIn. The PMCPA recorded the case as outwith the scope of the ABPI Code,…
Novartis-funded HF virtual meeting was deemed promotional despite being classed non-promotional. Meeting write-up promoted Entresto but omitted prescribing info, AE reporting and…
PMCPA found AbbVie’s Rinvoq RA/PsA webpages misleading: surfing imagery implied unrealistic outcomes and pages didn’t prominently flag pregnancy contraindication/contraception advice for women…
Sandoz supplied an Omnitrope cool bag costing £13.66 (over the £10 limit) and later withdrew it without proactive stakeholder communication. Breaches of…
Ferring confirmed withdrawal of Pentasa material with incorrect dosing info, but a hidden website hyperlink kept the leavepiece accessible for ~11 weeks.…
A LinkedIn sponsored message promoting Ogluo (glucagon) was received by a non-HCP. The Panel found public promotion plus missing INN at first…
A pharmacy training webinar hosted on a member site/YouTube became promotional when Valneva’s speaker mentioned products and “no competitors”, triggering missing AE…
A UK AstraZeneca employee ‘liked’ a third-party LinkedIn post about positive phase 3 datopotamab deruxtecan results. The Panel said the ‘like’ disseminated…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.